# Dehydroepiandrosterone (DHEA) Intervention To Treat Ovarian Aging

> **NCT01572025** · PHASE3 · COMPLETED · sponsor: **University of Nottingham** · enrollment: 60 (actual)

## Conditions studied

- Infertility
- Ovarian Aging
- Diminished Ovarian Reserve (DOR)
- Predicted Poor-responders

## Interventions

- **DRUG:** Dehydroepiandrosterone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01572025
- **Lead sponsor:** University of Nottingham
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2015-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01572025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01572025, "Dehydroepiandrosterone (DHEA) Intervention To Treat Ovarian Aging". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01572025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*